超人智能(08176.HK)附屬就美容合約訂立轉讓及約務更替契據
超人智能(08176.HK)公布,於6月30日聯交所交易時段後,公司之間接非全資附屬公司創康與CPCL訂立轉讓及約務更替契據,CPCL同意承擔創康於該等合約項下之所有責任及負債,而創康同意向CPCL轉讓其於該等合約之所有權利、利益及權益(包括預付款項)。
估計於完成轉讓及約務更替契據項下之交易後,集團將錄得收益約400萬元,即合約負債與預付款項之差額。集團已決定於6月30日起終止經營美容業務,轉讓及約務更替契據之條款及條件屬公平合理,並符合公司及股東之整體利益。(el/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.